{"id":36631,"date":"2026-02-11T06:37:07","date_gmt":"2026-02-11T06:37:07","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/clinical-trial-patient-recruitment-services-market-mordor\/"},"modified":"2026-03-27T20:44:08","modified_gmt":"2026-03-27T11:44:08","slug":"clinical-trial-patient-recruitment-services-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/clinical-trial-patient-recruitment-services-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc784\uc0c1\uc2dc\ud5d8 \ud658\uc790 \ubaa8\uc9d1 \uc11c\ube44\uc2a4 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d: \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026-2031\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/clinical-trial-patient-recruitment-services-market-1750142970806-major-players.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/clinical-trial-patient-recruitment-services-market-size-image-1768931323739.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uc804 \uc138\uacc4 \uc784\uc0c1 \uc2dc\ud5d8 \uc218 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.2 \ub2e4\uc591\ud55c \ud658\uc790 \uc9d1\ub2e8\uc5d0 \ub300\ud55c \uc218\uc694<\/li>\n<li class=\"toc-level-3\">4.2.3 \ud76c\uadc0 \ubc0f \ucd08\ud76c\uadc0 \uc9c8\ud658 \uc720\ubcd1\ub960 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.4 AI \uae30\ubc18 \uc608\uce21 \ub4f1\ub85d \ubd84\uc11d<\/li>\n<li class=\"toc-level-3\">4.2.5 \ubd84\uc0b0\ud615 \ubc0f \ud558\uc774\ube0c\ub9ac\ub4dc \uc784\uc0c1 \uc2dc\ud5d8 \ubaa8\ub378\uc758 \uc131\uc7a5<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \uc704\ud5d8 \ubc0f \ubd80\uc791\uc6a9\uc5d0 \ub300\ud55c \ud658\uc790 \uc6b0\ub824<\/li>\n<li class=\"toc-level-3\">4.3.2 \ubcf5\uc7a1\ud55c \uc790\uaca9 (\ud3ec\ud568\/\uc81c\uc678) \uae30\uc900<\/li>\n<li class=\"toc-level-3\">4.3.3 \uc99d\uac00\ud558\ub294 \uae00\ub85c\ubc8c \ub370\uc774\ud130 \uac1c\uc778 \uc815\ubcf4 \ubcf4\ud638 \uaddc\uc815<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.5 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.5.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.5.2 \uad6c\ub9e4\uc790\/\uc2a4\ud3f0\uc11c\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.5.3 \uc11c\ube44\uc2a4 \uc81c\uacf5\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.5.4 \ub300\uccb4 \uc194\ub8e8\uc158\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.5.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58, USD)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \ub2e8\uacc4\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 1\uc0c1<\/li>\n<li class=\"toc-level-3\">5.1.2 2\uc0c1<\/li>\n<li class=\"toc-level-3\">5.1.3 3\uc0c1<\/li>\n<li class=\"toc-level-3\">5.1.4 4\uc0c1<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uce58\ub8cc \ubd84\uc57c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \uc885\uc591\ud559<\/li>\n<li class=\"toc-level-3\">5.2.2 \uc2ec\ud608\uad00<\/li>\n<li class=\"toc-level-3\">5.2.3 \uc911\ucd94\uc2e0\uacbd\uacc4<\/li>\n<li class=\"toc-level-3\">5.2.4 \ub0b4\ubd84\ube44 &amp; \ub300\uc0ac<\/li>\n<li class=\"toc-level-3\">5.2.5 \uac10\uc5fc\ubcd1<\/li>\n<li class=\"toc-level-3\">5.2.6 \uae30\ud0c0 \uce58\ub8cc \ubd84\uc57c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \uc11c\ube44\uc2a4 \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \ud658\uc790 \ub370\uc774\ud130\ubca0\uc774\uc2a4 &amp; \ud0c0\ub2f9\uc131 \uc11c\ube44\uc2a4<\/li>\n<li class=\"toc-level-3\">5.3.2 \uc2dc\ud5d8\uae30\uad00 \uc2dd\ubcc4 &amp; \ucc38\uc5ec<\/li>\n<li class=\"toc-level-3\">5.3.3 \ub514\uc9c0\ud138 \/ \uc18c\uc15c \ubbf8\ub514\uc5b4 \ubaa8\uc9d1<\/li>\n<li class=\"toc-level-3\">5.3.4 \uc9c0\uc5ed\uc0ac\ud68c \uae30\ubc18 \/ \uc544\uc6c3\ub9ac\uce58 \ud504\ub85c\uadf8\ub7a8<\/li>\n<li class=\"toc-level-3\">5.3.5 \uc720\uc9c0 &amp; \uaddc\uc815 \uc900\uc218 \uc11c\ube44\uc2a4<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \ubaa8\uc9d1 \ucc44\ub110\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \uc5f0\uad6c\uc790-\uae30\uad00 \uc8fc\ub3c4<\/li>\n<li class=\"toc-level-3\">5.4.2 CRO \uc8fc\ub3c4<\/li>\n<li class=\"toc-level-3\">5.4.3 \ud658\uc790 \uc9c1\uc811 (\uc628\ub77c\uc778 \/ \ubaa8\ubc14\uc77c)<\/li>\n<li class=\"toc-level-3\">5.4.4 \ud658\uc790 \uc639\ud638 \ub2e8\uccb4 \ud30c\ud2b8\ub108\uc2ed<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \uc2a4\ud3f0\uc11c \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \uc81c\uc57d &amp; \ubc14\uc774\uc624 \uae30\uc5c5<\/li>\n<li class=\"toc-level-3\">5.5.2 \uc758\ub8cc\uae30\uae30 \uae30\uc5c5<\/li>\n<li class=\"toc-level-3\">5.5.3 \uae30\ud0c0 \uc2a4\ud3f0\uc11c \uc720\ud615<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.6 \uc9c0\uc5ed\n<ul>\n<li class=\"toc-level-3\">5.6.1 \ubd81\ubbf8\n<ul>\n<li class=\"toc-level-4\">5.6.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.6.1.3 \uba55\uc2dc\ucf54<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.6.2 \uc720\ub7fd\n<ul>\n<li class=\"toc-level-4\">5.6.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.6.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.6.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.6.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.6.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.6.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591\n<ul>\n<li class=\"toc-level-4\">5.6.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.6.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.6.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.6.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.6.4 \uc911\ub3d9 &amp; \uc544\ud504\ub9ac\uce74\n<ul>\n<li class=\"toc-level-4\">5.6.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.6.4.2 \ub0a8\uc544\ud504\ub9ac\uce74 \uacf5\ud654\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.4.3 \uae30\ud0c0 \uc911\ub3d9 &amp; \uc544\ud504\ub9ac\uce74<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.6.5 \ub0a8\uc544\uba54\ub9ac\uce74\n<ul>\n<li class=\"toc-level-4\">5.6.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.6.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.6.5.3 \uae30\ud0c0 \ub0a8\uc544\uba54\ub9ac\uce74<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \uc0ac\uc5c5 \ubd80\ubb38, \uc7ac\ubb34, \uc778\ub825, \uc8fc\uc694 \uc815\ubcf4, \uc2dc\uc7a5 \uc21c\uc704, \uc2dc\uc7a5 \uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ubd84\uc11d \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 IQVIA<\/li>\n<li class=\"toc-level-3\">6.3.2 ICON plc<\/li>\n<li class=\"toc-level-3\">6.3.3 Syneos Health<\/li>\n<li class=\"toc-level-3\">6.3.4 Parexel International<\/li>\n<li class=\"toc-level-3\">6.3.5 Labcorp Drug Development<\/li>\n<li class=\"toc-level-3\">6.3.6 BBK Worldwide<\/li>\n<li class=\"toc-level-3\">6.3.7 Antidote Technologies<\/li>\n<li class=\"toc-level-3\">6.3.8 AutoCruitment<\/li>\n<li class=\"toc-level-3\">6.3.9 Elligo Health Research<\/li>\n<li class=\"toc-level-3\">6.3.10 Worldwide Clinical Trials<\/li>\n<li class=\"toc-level-3\">6.3.11 Biorasi<\/li>\n<li class=\"toc-level-3\">6.3.12 Trialbee<\/li>\n<li class=\"toc-level-3\">6.3.13 M&amp;B Sciences<\/li>\n<li class=\"toc-level-3\">6.3.14 TrialSpark<\/li>\n<li class=\"toc-level-3\">6.3.15 Clara Health<\/li>\n<li class=\"toc-level-3\">6.3.16 Verily Life Sciences<\/li>\n<li class=\"toc-level-3\">6.3.17 Deep 6 AI<\/li>\n<li class=\"toc-level-3\">6.3.18 PicnicHealth<\/li>\n<li class=\"toc-level-3\">6.3.19 ClinicalConnection<\/li>\n<li class=\"toc-level-3\">6.3.20 PatientWing<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uc784\uc0c1\uc2dc\ud5d8 \ud658\uc790 \ubaa8\uc9d1 \uc11c\ube44\uc2a4 \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc804\ub9dd (2026-2031)<\/p>\n<p>\uc784\uc0c1\uc2dc\ud5d8 \ud658\uc790 \ubaa8\uc9d1 \uc11c\ube44\uc2a4 \uc2dc\uc7a5\uc740 2025\ub144 10\uc5b5 6\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 2026\ub144 11\uc5b5 4\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \uc131\uc7a5\ud588\uc73c\uba70, 2031\ub144\uc5d0\ub294 16\uc5b5 6\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \ub2ec\ud560 \uac83\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4. \uc774\ub294 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 7.78%\ub97c \uae30\ub85d\ud560 \uc804\ub9dd\uc785\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc131\uc7a5\uc740 \uc784\uc0c1\uc2dc\ud5d8\uc758 \uc778\uad6c\ud1b5\uacc4\ud559\uc801 \ub2e4\uc591\uc131 \ubd80\uc871\uc5d0 \ub300\ud55c \uaddc\uc81c \uac15\ud654, AI \uae30\ubc18 \ucc38\uac00\uc790 \uc2dd\ubcc4 \uae30\uc220\uc758 \ubc1c\uc804, \ubd84\uc0b0\ud615 \ubc0f \ud558\uc774\ube0c\ub9ac\ub4dc \uc5f0\uad6c \ubaa8\ub378\uc758 \ucc44\ud0dd \uac00\uc18d\ud654\uc5d0 \ud798\uc785\uc740 \ubc14 \ud07d\ub2c8\ub2e4. \uc2a4\ud3f0\uc11c\ub4e4\uc740 \uc784\uc0c1\uc2dc\ud5d8 \uae30\uac04 \ub2e8\ucd95\uc744 \uc704\ud574 \ubaa8\uc9d1 \ud50c\ub7ab\ud3fc\uc5d0 \ub354 \ub9ce\uc740 \uc608\uc0b0\uc744 \ud560\ub2f9\ud558\uace0 \uc788\uc73c\uba70, \uae30\uc220 \uacf5\uae09\uc5c5\uccb4\ub4e4\uc740 \ubc29\ub300\ud55c \uac74\uac15 \ub370\uc774\ud130\uc5d0 \uc608\uce21 \ubd84\uc11d\uc744 \uc801\uc6a9\ud558\uc5ec \ud658\uc790 \ubaa8\uc9d1\uc758 \ud6a8\uc728\uc131\uc744 \ub192\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc18c\uc15c \ubbf8\ub514\uc5b4 \ub9c8\uc774\ud06c\ub85c \ud0c0\uac9f\ud305\uc744 \ud65c\uc6a9\ud55c \uc9c1\uc811 \ud658\uc790(Direct-to-Patient) \uc804\ub7b5\uc740 \uc9c0\ub9ac\uc801 \uc7a5\ubcbd\uc744 \ub0ae\ucd94\uace0 \ub4f1\ub85d\ub960\uc744 \ub192\uc774\ub294 \ub370 \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub610\ud55c, \uacc4\uc57d \uc5f0\uad6c \uae30\uad00(CRO)\uacfc \ub514\uc9c0\ud138 \ud5ec\uc2a4 \uae30\uc5c5 \uac04\uc758 \ud65c\ubc1c\ud55c M&#038;A \ud65c\ub3d9\uc740 \uc0ac\uc774\ud2b8 \uc120\uc815, \ubaa8\uc9d1, \uc720\uc9c0 \ubc0f \ub370\uc774\ud130 \ucea1\ucc98 \uae30\ub2a5\uc744 \ud1b5\ud569\ud558\ub294 \ud480\uc2a4\ud0dd \uc11c\ube44\uc2a4 \uc81c\uacf5\uc73c\ub85c\uc758 \uc804\ud658\uc744 \uc2dc\uc0ac\ud569\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc5ed\ub3d9\uc801\uc778 \ubcc0\ud654\ub294 \uc784\uc0c1\uc2dc\ud5d8 \uc0b0\uc5c5\uc758 \ud6a8\uc728\uc131\uacfc \uc811\uadfc\uc131\uc744 \ud06c\uac8c \ud5a5\uc0c1\uc2dc\ud0a4\uba70, \uad81\uadf9\uc801\uc73c\ub85c\ub294 \uc2e0\uc57d \uac1c\ubc1c \uacfc\uc815\uc744 \uac00\uc18d\ud654\ud560 \uac83\uc73c\ub85c \uae30\ub300\ub429\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc784\uc0c1\uc2dc\ud5d8 \ud658\uc790 \ubaa8\uc9d1 \uc11c\ube44\uc2a4 \uc2dc\uc7a5\uc5d0 \ub300\ud55c \uc2ec\uce35 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc774 \uc2dc\uc7a5\uc740 \ubc14\uc774\uc624 \uc81c\uc57d \uc2a4\ud3f0\uc11c \ubc0f \uc784\uc0c1\uc2dc\ud5d8\uc218\ud0c1\uae30\uad00(CRO)\uc744 \ub300\uc2e0\ud558\uc5ec \ubaa8\ub4e0 \uc784\uc0c1 \ub2e8\uacc4\uc5d0 \uac78\uccd0 \uc911\uc7ac\uc801 \uc784\uc0c1 \uc5f0\uad6c\ub97c \uc704\ud55c \uc778\uac04 \ucc38\uac00\uc790\ub97c \uc2dd\ubcc4, \uc120\ubcc4, \ucc38\uc5ec \uc720\ub3c4, \ub4f1\ub85d \ubc0f \uc720\uc9c0\ud558\ub294 \uc720\ub8cc \uc81c3\uc790 \ud65c\ub3d9\uc73c\ub85c \uc815\uc758\ub429\ub2c8\ub2e4. \uc11c\ube44\uc2a4 \ubc94\uc704\ub294 \ub370\uc774\ud130\ubca0\uc774\uc2a4 \ub9c8\uc774\ub2dd, \uc9c0\ub9ac \ud0c0\uac9f\ud305 \ub514\uc9c0\ud138 \ud64d\ubcf4\ubd80\ud130 \ud604\uc7a5 \uad11\uace0 \ubc0f \uc5ec\ud589 \ubb3c\ub958\uc5d0 \uc774\ub974\uae30\uae4c\uc9c0 \uad11\ubc94\uc704\ud558\uba70, \ud6c4\ubc29 \uc0ac\uc774\ud2b8 \uad00\ub9ac, \ub370\uc774\ud130 \uad00\ub9ac \ubc0f \uc77c\ubc18 \uc784\uc0c1 \uacf5\uae09 \ubb3c\ub958\ub294 \uc81c\uc678\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc784\uc0c1\uc2dc\ud5d8 \ud658\uc790 \ubaa8\uc9d1 \uc11c\ube44\uc2a4 \uc2dc\uc7a5\uc740 2026\ub144 11\uc5b5 4\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\uc774\uba70, 2031\ub144\uae4c\uc9c0 7.78%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR)\ub85c \uc131\uc7a5\ud558\uc5ec 16\uc5b5 6\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \uc131\uc7a5 \ub3d9\ub825\uc73c\ub85c\ub294 \uc804 \uc138\uacc4 \uc784\uc0c1\uc2dc\ud5d8 \uc218\uc758 \uc9c0\uc18d\uc801\uc778 \uc99d\uac00, \ub2e4\uc591\ud55c \ud658\uc790 \ubaa8\uc9d1\ub2e8\uc5d0 \ub300\ud55c \uc218\uc694 \uc99d\ub300, \ud76c\uadc0 \ubc0f \ucd08\ud76c\uadc0 \uc9c8\ud658\uc758 \uc720\ubcd1\ub960 \uc0c1\uc2b9, AI \uae30\ubc18 \uc608\uce21 \ub4f1\ub85d \ubd84\uc11d\uc758 \ud65c\uc6a9 \ud655\ub300, \uadf8\ub9ac\uace0 \ubd84\uc0b0\ud615 \ubc0f \ud558\uc774\ube0c\ub9ac\ub4dc \uc784\uc0c1\uc2dc\ud5d8 \ubaa8\ub378\uc758 \ud655\uc0b0\uc774 \uc788\uc2b5\ub2c8\ub2e4. \ud2b9\ud788 AI \uae30\ubc18 \uc608\uce21 \ubd84\uc11d\uc740 \ub4f1\ub85d \uc8fc\uae30\ub97c 10-15% \ub2e8\ucd95\ud558\uace0 \ucd5c\uc801\uc758 \uc5f0\uad6c\uc790 \uc0ac\uc774\ud2b8\ub97c \uc2dd\ubcc4\ud558\uc5ec \uc804\uccb4 \uac1c\ubc1c \uc77c\uc815\uc744 \ucd5c\ub300 6\uac1c\uc6d4\uae4c\uc9c0 \uc808\uac10\ud560 \uc218 \uc788\ub294 \uc7a0\uc7ac\ub825\uc744 \uac00\uc9c0\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub610\ud55c, FDA\uc758 \uc778\uad6c\ud1b5\uacc4\ud559\uc801 \ub4f1\ub85d \ubaa9\ud45c \uc81c\ucd9c \uc758\ubb34\ud654\ub294 \uc18c\uc678\ub41c \uc9d1\ub2e8\uc744 \ucc38\uc5ec\uc2dc\ud0a4\ub294 \ubaa8\uc9d1 \uc804\ub7b5\uc758 \uc911\uc694\uc131\uc744 \ub354\uc6b1 \ucee4\uc9c0\uac8c \ud558\uc5ec \uc2dc\uc7a5 \uc131\uc7a5\uc744 \ucd09\uc9c4\ud558\ub294 \uc8fc\uc694 \uae30\ud68c \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4.<\/p>\n<p>\ubc18\uba74, \ud658\uc790\uc758 \uc7a0\uc7ac\uc801 \uc704\ud5d8 \ubc0f \ubd80\uc791\uc6a9\uc5d0 \ub300\ud55c \uc6b0\ub824, \ubcf5\uc7a1\ud55c \ucc38\uc5ec \uc790\uaca9(\ud3ec\ud568\/\uc81c\uc678) \uae30\uc900, \uadf8\ub9ac\uace0 \uac15\ud654\ub418\ub294 \uae00\ub85c\ubc8c \ub370\uc774\ud130 \ud504\ub77c\uc774\ubc84\uc2dc \uaddc\uc81c\ub294 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc8fc\uc694 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5\uc740 \uc784\uc0c1 \ub2e8\uacc4(1\uc0c1, 2\uc0c1, 3\uc0c1, 4\uc0c1), \uce58\ub8cc \uc601\uc5ed(\uc885\uc591\ud559, \uc2ec\ud608\uad00, \uc911\ucd94\uc2e0\uacbd\uacc4, \ub0b4\ubd84\ube44 \ubc0f \ub300\uc0ac, \uac10\uc5fc\ubcd1 \ub4f1), \uc11c\ube44\uc2a4 \uc720\ud615(\ud658\uc790 \ub370\uc774\ud130\ubca0\uc774\uc2a4 \ubc0f \ud0c0\ub2f9\uc131, \uc0ac\uc774\ud2b8 \uc2dd\ubcc4 \ubc0f \ucc38\uc5ec, \ub514\uc9c0\ud138\/\uc18c\uc15c \ubbf8\ub514\uc5b4 \ubaa8\uc9d1, \ucee4\ubba4\ub2c8\ud2f0 \uae30\ubc18 \ud504\ub85c\uadf8\ub7a8, \uc720\uc9c0 \ubc0f \uc900\uc218 \uc11c\ube44\uc2a4), \ubaa8\uc9d1 \ucc44\ub110(\uc5f0\uad6c\uc790 \uc8fc\ub3c4, CRO \uc8fc\ub3c4, \ud658\uc790 \uc9c1\uc811, \ud658\uc790 \uc639\ud638 \ub2e8\uccb4 \ud30c\ud2b8\ub108\uc2ed), \uc2a4\ud3f0\uc11c \uc720\ud615(\uc81c\uc57d \ubc0f \ubc14\uc774\uc624\ud14d, \uc758\ub8cc\uae30\uae30 \ud68c\uc0ac \ub4f1) \ubc0f \uc9c0\uc5ed\ubcc4\ub85c \uc138\ubd84\ud654\ub429\ub2c8\ub2e4. \uc774 \uc911 3\uc0c1 \uc784\uc0c1\uc2dc\ud5d8\uc774 2025\ub144 \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 45.74%\ub97c \ucc28\uc9c0\ud558\uba70 \ud658\uc790 \ubaa8\uc9d1 \uc9c0\ucd9c\uc5d0\uc11c \uac00\uc7a5 \ud070 \ube44\uc911\uc744 \ucc28\uc9c0\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\uc5ed\ubcc4\ub85c\ub294 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 \uac04\uc18c\ud654\ub41c \uc2b9\uc778 \uc808\ucc28\uc640 \ubd84\uc0b0\ud615 \uc784\uc0c1\uc2dc\ud5d8 \uc778\ud504\ub77c\uc5d0 \ub300\ud55c \uac15\ub825\ud55c \ud22c\uc790\uc5d0 \ud798\uc785\uc5b4 9.44%\uc758 \uac00\uc7a5 \ub192\uc740 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \ubcf4\uc774\uba70 \ube60\ub974\uac8c \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd \ubd84\uc11d\uc5d0\uc11c\ub294 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d, \uadf8\ub9ac\uace0 IQVIA, ICON plc, Syneos Health, Parexel International, Labcorp Drug Development \ub4f1 \uc8fc\uc694 20\uac1c \uae30\uc5c5\uc758 \ud504\ub85c\ud544\uc774 \ud3ec\ud568\ub429\ub2c8\ub2e4. \uc2dc\uc7a5\uc740 \ub300\ud615 CRO\ub4e4\uc774 \uae30\uc220 \ud601\uc2e0 \uae30\uc5c5\uc744 \uc778\uc218\ud558\uace0(\uc608: ICON\uc758 PRA Health Sciences 120\uc5b5 \ub2ec\ub7ec \uc778\uc218), \uc18c\ub9e4 \uc57d\uad6d \ubc0f AI \uc2a4\ud0c0\ud2b8\uc5c5\uc774 \uc11c\ube44\uc2a4 \ubaa8\ub378\uc744 \ub2e4\uac01\ud654\ud558\uba70 \uacbd\uc7c1 \uad6c\ub3c4\ub97c \uc7ac\ud3b8\ud558\ub294 \uc591\uc0c1\uc744 \ubcf4\uc785\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc2ec\uce35\uc801\uc778 \uc5f0\uad6c \ubc29\ubc95\ub860\uc744 \uae30\ubc18\uc73c\ub85c \ud569\ub2c8\ub2e4. 1\ucc28 \uc5f0\uad6c(\uc870\uc0ac\uc790, \uc5f0\uad6c \ucf54\ub514\ub124\uc774\ud130, \ubaa8\uc9d1 \uae30\uc220 \uacf5\uae09\uc5c5\uccb4, CRO \uac00\uaca9 \uad00\ub9ac\uc790\uc640\uc758 \ubc18\uc815\ud615\ud654\ub41c \uc778\ud130\ubdf0)\uc640 2\ucc28 \uc5f0\uad6c(ClinicalTrials.gov, EU-CTR, FDA, EMA \ub370\uc774\ud130, PhRMA, TransCelerate, Tufts CSDD \ub4f1 \uc0b0\uc5c5 \ub2e8\uccb4 \ubcf4\uace0\uc11c, \uae30\uc5c5 \uc7ac\ubb34 \uc790\ub8cc, \ud559\uc220 \uc800\ub110 \ub4f1)\ub97c \ud1b5\ud574 \ub370\uc774\ud130\ub97c \uc218\uc9d1\ud558\uace0 \uac80\uc99d\ud588\uc2b5\ub2c8\ub2e4. \uc2dc\uc7a5 \uaddc\ubaa8 \uc0b0\uc815 \ubc0f \uc608\uce21\uc740 \uc0c1\ud5a5\uc2dd \ubc0f \ud558\ud5a5\uc2dd \uc811\uadfc \ubc29\uc2dd\uc744 \ubcd1\ud589\ud558\uba70, \ub4f1\ub85d\ub41c \uc784\uc0c1\uc2dc\ud5d8 \uc218, \ud658\uc790\ub2f9 \ud3c9\uade0 \ube44\uc6a9, \uc2a4\ud06c\ub9ac\ub2dd \uc2e4\ud328\uc728, \ub514\uc9c0\ud138 \ubc0f \ud604\uc7a5 \uc8fc\ub3c4 \ubaa8\uc9d1 \ube44\uc911, \ubd84\uc0b0\ud615\/\ud558\uc774\ube0c\ub9ac\ub4dc \uc784\uc0c1\uc2dc\ud5d8 \ucc44\ud0dd\ub960 \ub4f1\uc758 \ud575\uc2ec \uc9c0\ud45c\ub97c \ud65c\uc6a9\ud569\ub2c8\ub2e4. \ub370\uc774\ud130\ub294 \uc5f0\uac04 \uc5c5\ub370\uc774\ud2b8\ub418\uba70, \uc8fc\uc694 \uc2dc\uc7a5 \ubcc0\ud654 \ubc1c\uc0dd \uc2dc \uc218\uc2dc\ub85c \uac31\uc2e0\ub429\ub2c8\ub2e4. Mordor Intelligence\uc758 \ubd84\uc11d\uc740 \ub2e4\ub978 \ubcf4\uace0\uc11c\ub4e4\uacfc \ub2ec\ub9ac \uc11c\ube44\uc2a4 \ubc94\uc704, \uac00\uaca9 \uad6c\uc870, \uc5c5\ub370\uc774\ud2b8 \uc8fc\uae30 \ub4f1\uc758 \ucc28\uc774\ub97c \uba85\ud655\ud788 \ud558\uace0, \uac80\uc99d\ub41c \uc784\uc0c1\uc2dc\ud5d8 \ub4f1\ub85d \uac74\uc218\uc640 \ud604\uc7ac \uacf5\uae09\uc5c5\uccb4 \uacac\uc801\uc744 \uad50\ucc28 \ud655\uc778\ud558\uc5ec \uc2e0\ub8b0\uc131 \ub192\uc740 \uae30\uc900\uc810\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-36631","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/36631"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=36631"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/36631\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=36631"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=36631"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=36631"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}